These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16185511)

  • 1. [Advances in lymphangiogenesis and metastasis of tumor].
    Yan XC; Yu DM; Liu FX
    Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):370-2. PubMed ID: 16185511
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advances on lymphangiogenesis and lymphatic metastasis].
    Liu FF; Lang RG; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):267-70. PubMed ID: 17706122
    [No Abstract]   [Full Text] [Related]  

  • 4. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
    Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
    Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targeting of lymphatics for therapy.
    Stacker SA; Hughes RA; Achen MG
    Curr Pharm Des; 2004; 10(1):65-74. PubMed ID: 14754406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced lymphangiogenesis: a target for cancer therapy?
    Thiele W; Sleeman JP
    J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.
    Yonemura Y; Endo Y; Tabata K; Kawamura T; Yun HY; Bandou E; Sasaki T; Miura M
    Int J Clin Oncol; 2005 Oct; 10(5):318-27. PubMed ID: 16247658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological N0 squamous cell carcinoma of the tongue.
    Hirota K; Wakisaka N; Sawada-Kitamura S; Kondo S; Endo K; Tsuji A; Murono S; Yoshizaki T
    Histopathology; 2012 Dec; 61(6):1065-71. PubMed ID: 22957497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship between lymphangiogenesis and lymphatic metastasis in murine hepatic carcinoma of high and low metastatic potentialities].
    Wang KF; Ye SL; Song LJ; Weng YQ; Liang CM; Zhao Y; Gao DM; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):187-91. PubMed ID: 16556412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.
    Qin T; Huang D; Liu Z; Zhang X; Jia Y; Xian CJ; Li K
    Cancer Sci; 2018 Aug; 109(8):2469-2478. PubMed ID: 29890027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why and how do tumors stimulate lymphangiogenesis?
    Cao Y
    Lymphat Res Biol; 2008; 6(3-4):145-8. PubMed ID: 19093786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
    Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
    Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic vessel density as a predictor of lymph node metastasis and its relationship with prognosis in urothelial carcinoma of the bladder.
    Zhou M; He L; Zu X; Zhang H; Zeng H; Qi L
    BJU Int; 2011 Jun; 107(12):1930-5. PubMed ID: 20883486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphangiogenesis].
    Hosono K; Majima M
    Nihon Yakurigaku Zasshi; 2013 May; 141(5):290-1. PubMed ID: 23665561
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
    Saharinen P; Tammela T; Karkkainen MJ; Alitalo K
    Trends Immunol; 2004 Jul; 25(7):387-95. PubMed ID: 15207507
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advance in lymphangiogenesis of colorectal carcinoma].
    Li LR; Wan DS
    Ai Zheng; 2006 Mar; 25(3):382-4. PubMed ID: 16537000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.